Rapport Therapeutics Inc....
(RAPP)
undefined
undefined%
At close: undefined
15.10
-19.85%
Pre-market Dec 16, 2024, 04:06 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 |
Net Income | -34.79M | -10.65M |
Depreciation & Amortization | 112.00K | 15.00K |
Stock-Based Compensation | 3.52M | - |
Other Working Capital | 1.80M | 1.49M |
Other Non-Cash Items | 1.32M | 5.94M |
Deferred Income Tax | - | - |
Change in Working Capital | 2.65M | 1.49M |
Operating Cash Flow | -27.18M | -3.24M |
Capital Expenditures | -1.64M | -284.00K |
Acquisitions | - | - |
Purchase of Investments | -77.22M | - |
Sales Maturities Of Investments | - | - |
Other Investing Acitivies | - | -5.00M |
Investing Cash Flow | -78.86M | -5.28M |
Debt Repayment | - | 7.90M |
Common Stock Repurchased | -4.00K | - |
Dividend Paid | - | - |
Other Financial Acitivies | 145.09M | - |
Financial Cash Flow | 145.14M | 39.69M |
Net Cash Flow | 39.09M | 31.16M |
Free Cash Flow | -28.82M | -3.53M |